Anti-angiogenic action of the C-terminal domain of tenomodulin that shares homology with chondromodulin-I

Journal of Cell Science

Volumn 117, Issue 13, 2004, Pages 2731-2744

  Oshima, Yusuke ^a,b   Sato, Koji ^a   Tashiro, Fumi ^b   Miyazaki, Jun Ichi ^b   Nishida, Koji ^b   Hiraki, Yuji ^a   Tano, Yasuo ^b   Shukunami, Chisa ^a  

^a KYOTO UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Angiogenesis inhibitor; Chondromodulin I; Tendon; Tenomodulin

Indexed keywords

ADENOVIRUS VECTOR; ANGIOGENESIS INHIBITOR; CHRONOMODULIN I; COLLAGEN TYPE 1; FIBRONECTIN; MATRIGEL; MEMBRANE PROTEIN; PLASMID DNA; PROTEIN PRECURSOR; TENOMODULIN; UNCLASSIFIED DRUG; VASCULOTROPIN; VITRONECTIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CARBOXY TERMINAL SEQUENCE; CELL ASSAY; CELL FUNCTION; CELL MIGRATION; CELL STRAIN COS7; CONTROLLED STUDY; CULTURE MEDIUM; DNA SYNTHESIS; ENDOTHELIUM CELL; EXPRESSION VECTOR; GENETIC CODE; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VIVO STUDY; MELANOMA CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN SECRETION; SEQUENCE HOMOLOGY; TUMOR GROWTH; UMBILICAL VEIN;

ADENOVIRIDAE; ANGIOGENESIS INHIBITORS; ANIMALS; CELL LINE; CELL MOVEMENT; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COLLAGEN; COLLAGEN TYPE I; COS CELLS; CULTURE MEDIA, CONDITIONED; DNA; DRUG COMBINATIONS; ENDOTHELIUM, VASCULAR; FIBRONECTINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LAMININ; MELANOCYTES; MELANOMA; MELANOMA, EXPERIMENTAL; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; PROTEIN STRUCTURE, TERTIARY; PROTEOGLYCANS; TRANSPLANTATION, HOMOLOGOUS; TUMOR CELLS, CULTURED; UMBILICAL VEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ADENOVIRIDAE; ANIMALIA; VECTORS;

EID: 3242892856     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.01112     Document Type: Article

References (44)

1. Azizan, A., Holaday, N. and Neame, P. J. (2001). Post-translational processing of bovine chondromodulin-I. J. Biol. Chem. 276, 23632-23638.
2. Barr, P. J. (1991). Mammalian subtilisins: the long-sought dibasic processing endoproteases. Cell 66, 1-3.
3. Benjamin, M. and Ralphs, J. R. (2000). The cell and developmental biology of tendons and ligaments. Int. Rev. Cytol. 196, 85-130.
4. Black, R. A. and White, J. M. (1998). ADAMs: focus on the protease domain. Curr. Opin. Cell Biol. 10, 654-659.
5. Brandau, O., Meindl, A., Fassler, R. and Aszodi, A. (2001). A novel gene, tendin, is strongly expressed in tendons and ligaments and shows high homology with chondromodulin-I. Dev. Dyn. 221, 72-80.
6. Brooks, P. C., Clark, R. A. and Cheresh, D. A. (1994). Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 264, 569-571.
7. Cao, Y., Chen, A., An, S. S., Ji, R. W., Davidson, D. and Llinas, M. (1997). Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth. J. Biol. Chem. 272, 22924-22928.
8. Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C. et al. (1996). Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435-439.
9. Eliceiri, B. P. and Cheresh, D. A. (1999). The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical development. J. Clin. Invest. 103, 1227-1230.
10. Folkman, J. and Haudenschild, C. (1980). Angiogenesis in vitro. Nature 288, 551-556.
11. Grant, D. S., Lelkes, P. I., Fukuda, K. and Kleinman, H. K. (1991). Intracellular mechanisms involved in basement membrane induced blood vessel differentiation in vitro. In Vitro Cell Dev. Biol. 27A, 327-336.
12. Hata, Y., Rook, S. L. and Aiello, L. P. (1999). Basic fibroblast growth factor induces expression of VEGF receptor KDR through a protein kinase C and p44/p42 mitogen-activated protein kinase- dependent pathway. Diabetes 48, 1145-1155.
13. Hayami, T., Shukunami, C., Mitsui, K., Endo, N., Tokunaga, K., Kondo, J., Takahashi, H. E. and Hiraki, Y. (1999). Specific loss of chondromodulin-I gene expression in chondrosarcoma and the suppression of tumor angiogenesis and growth by its recombinant protein in vivo. FEBS Lett. 458, 436-440.
14. Hiraki, Y., Inoue, H., Iyama, K., Kamizono, A., Ochiai, M., Shukunami, C., Iijima, S., Suzuki, F. and Kondo, J. (1997). Identification of chondromodulin I as a novel endothelial cell growth inhibitor. Purification and its localization in the avascular zone of epiphyseal cartilage. J. Biol. Chem. 272, 32419-32426.
15. Hiraki, Y., Mitsui, K., Endo, N., Takahashi, K., Hayami, T., Inoue, H., Shukunami, C., Tokunaga, K., Kono, T., Yamada, M. et al. (1999). Molecular cloning of human chondromodulin-I, a cartilage-derived growth modulating factor, and its expression in Chinese hamster ovary cells. Eur. J. Biochem. 260, 869-878.
16. Hiraki, Y., Tanaka, H., Inoue, H., Kondo, J., Kamizono, A. and Suzuki, F. (1991). Molecular cloning of a new class of cartilage-specific matrix, chondromodulin-I, which stimulates growth of cultured chondrocytes. Biochem. Biophys. Res. Commun. 175, 971-977.
17. Kheradmand, F. and Werb, Z. (2002). Shedding light on sheddases: role in growth and development. BioEssays 24, 8-12.
18. Kuettner, K. E. and Pauli, B. U. (1983). Vascularity of cartilage. In Cartilage, vol. 1 (ed. B. K. Hall), pp. 281-312. New York: Academic Press.
19. Louis, C. and Sekeris, C. E. (1976). Isolation of informoferes from rat liver. Effects of alpha-amanitin and actinomycin D. Exp. Cell Res. 102, 317-328.
20. Mori, Y., Hiraki, Y., Shukunami, C., Kakudo, S., Shiokawa, M., Kagoshima, M., Mano, H., Hakeda, Y., Kurokawa, T., Suzuki, F. et al. (1997). Stimulation of osteoblast proliferation by the cartilage-derived growth promoting factors chondromodulin-I and -II. FEBS Lett. 406, 310-314.
21. Nakamichi, Y., Shukunami, C., Yamada, T., Aihara, K., Kawano, H., Sato, T., Nishizaki, Y., Yamamoto, Y., Shindo, M., Yoshimura, K. et al. (2003). Chondromodulin I is a bone remodeling factor. Mol. Cell. Biol. 23, 636-644.
22. Nakamura, T., Aoki, S., Kitajima, K., Takahashi, T. and Matsumoto, K. (2001). Molecular cloning and characterization of Kremen, a novel kringle-containing transmembrane protein. Biochim. Biophys. Acta 1518, 63-72.
23. Nakayama, J., Tsuchida, T., Toyofuku, K., Shimokawa-Kuroki, R., Taniguchi, S. and Hori, Y. (1994). Different sensitivities of the murine melanomas BL-6 and BL-6-beta m to local injections of interleukin-2 (IL-2). Analysis of gangliosides after the treatment. Melanoma Res. 4, 297-302
24. Namba, K., Abe, M., Saito, S., Satake, M., Ohmoto, T., Watanabe, T. and Sato, Y. (2000). Indispensable role of the transcription factor PEBP2/CBF in angiogenic activity of a murine endothelial cell MSS31. Oncogene 19, 106-114.
25. Neame, P. J., Treep, J. T. and Young, C. N. (1990). An 18-kDa glycoprotein from bovine nasal cartilage. Isolation and primary structure of small, cartilage-derived glycoprotein. J. Biol. Chem. 265, 9628-9633.
26. Niwa, H., Yamamura, K. and Miyazaki, J. (1991). Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108, 193-199.
27. O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R. and Folkman, J. (1997). Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88, 277-285.
28. O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H. and Folkman, J. (1994). Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315-328.
29. Sachdev, S. W., Dietz, U. H., Oshima, Y., Lang, M. R., Knapik, E. W., Hiraki, Y. and Shukunami, C. (2001). Sequence analysis of zebrafish chondromodulin-1 and expression profile in the notochord and chondrogenic regions during cartilage morphogenesis. Mech. Dev. 105, 157-162.
30. Sanchez-Pulido, L., Devos, D. and Valencia, A. (2002). BRICHOS: a conserved domain in proteins associated with dementia, respiratory distress and cancer. Trends Biochem. Sci. 27, 329-332.
31. Scopes, R. K. and Penny, I. F. (1971). Subunit sizes of muscle proteins, as determined by sodium dodecyl sulphate gel electrophoresis. Biochim. Biophys. Acta 236, 409-415.
32. Seetharam, L., Gotoh, N., Maru, Y., Neufeld, G., Yamaguchi, S. and Shibuya, M. (1995). A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endotheliat growth factor VEGF. Oncogene 10, 135-147.
33. Shukunami, C., Iyama, K., Inoue, H. and Hiraki, Y. (1999). Spatiotemporal pattern of the mouse chondromodulin-I gene expression and its regulatory role in vascular invasion into cartilage during endochondral bone formation. Int. J. Dev. Biol. 43, 39-49.
34. Shukunami, C., Oshima, Y. and Hiraki, Y. (2001). Molecular cloning of tenomodulin, a novel chondromodulin-I related gene. Biochem. Biophys. Res. Commun. 280, 1323-1327.
35. Sullivan, D. C. and Bicknell, R. (2003). New molecular pathways in angiogenesis. Br. J. Cancer 89, 228-231.
36. Suri, C., Jones, P. F., Patan, S., Bartunkova, S., Maisonpierre, P. C., Davis, S., Sato, T. N. and Yancopoulos, G. D. (1996). Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87, 1171-1180.
37. Tang, S., Gao, Y. and Ware, J. A. (1999). Enhancement of endothelial cell migration and in vitro tube formation by TAP20, a novel beta 5 integrin-modulating, PKC theta-dependent protein. J. Cell Biol. 147, 1073-1084.
38. Tarui, T., Miles, L. A. and Takada, Y. (2001). Specific interaction of angiostatin with integrin alpha(v)beta(3) in endothelial cells. J. Biol. Chem. 276, 39562-39568.
39. Tashiro, F., Niwa, H. and Miyazaki, J. (1999). Constructing adenoviral vectors by using the circular form of the adenoviral genome cloned in a cosmid and the Cre-loxP recombination system. Hum. Gene Ther 10, 1845-1852.
40. Tonini, T., Rossi, F. and Claudio, P. P. (2003). Molecular basis of angiogenesis and cancer. Oncogene 22, 6549-6556.
41. Yamana, K., Wada, H., Takahashi, Y., Sato, H., Kasahara, Y. and Kiyoki, M. (2001). Molecular cloning and characterization of CHM1L, a novel membrane molecule similar to chondromodulin-I. Biochem. Biophys. Res. Commun. 280, 1101-1106.
42. Young, B. and Heath, J. (2000). Connective tissues. In Wheater's Functional Histology (eds H. Burkitt, B. Young and J. Heath), pp. 97-192. Edinburgh, UK: Churchill Livingstone.
43. Zhai, Y., Ni, J., Jiang, G. W., Lu, J., Xing, L., Lincoln, C., Carter, K. C., Janat, F., Kozak, D., Xu, S. et al. (1999). VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivo. FASEB J. 13, 181-189.
44. Zhao, J., Chen, H., Peschon, J. J., Shi, W., Zhang, Y., Frank, S. J. and Warburton, D. (2001). Pulmonary hypoplasia in mice lacking tumor necrosis factor-alpha converting enzyme indicates an indispensable role for cell surface protein shedding during embryonic lung branching morphogenesis. Dev. Biol. 232, 204-218.